Insiders · Profile

Ocumension Therapeutics

Director at EyePoint. Filing since 5 Dec 2023. CIK 0001840315

Company

Date

Role

Action

Shares

Amount

Of holding

EYPT EyePoint, Inc.

11 Jan 2024

Director

Sold at will

1,910,500

$37.16M

95.0%

EYPT EyePoint, Inc.

6 Dec 2023

Director

Sold at will

266,242

$4.90M

11.7%

EYPT EyePoint, Inc.

5 Dec 2023

Director

Sold at will

733,758

$14.61M

24.4%

3 decisions on file.